The prediction of treatment outcomes for individual patients or patient populations, including tumor control and normal tissue toxicity, has always been of tremendous importance for driving clinical practice in Radiation Oncology and at the same time has been an active area within the research co

This cased-based panel focuses on the guideline recommendations and evidentiary basis for EBRT for HCC and IHC.

Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.

Breast cancer is one of the most common malignancies treated by radiation oncologists. Indications for radiation in patients with breast cancer are increasingly dependent on advances in surgery and systemic treatments and improved understanding of tumor biology.